Among the three breast cancer subtypes, hormone receptor-positive (HR+), human epidermal growth factor receptor 2-positive (HER2+), and triple-negative subtypes, the HR+ subtype comprises about 70% of all breast cancers [2]. This evidence concerns the gene NR4A1 and breast carcinoma.